摘要
我国结直肠癌发病率和死亡率均位于恶性肿瘤的前列,腹膜转移作为常见转移部位,是治疗失败的常见原因之一。目前结直肠癌腹膜转移的腹腔预防和治疗性药物种类繁多,但作用剂量和时间尚未形成规范化的治疗模式。因此为了规范术中预防和治疗性腹腔干预方法,中国医师协会结直肠肿瘤专业委员会组织国内相关领域权威专家,制定《结直肠癌腹膜转移预防和治疗腹腔用药中国专家共识》(以下简称《共识》),旨在提高我国结直肠肿瘤的整体诊治水平,延长结直肠癌患者生存时间并改善生活质量。
The morbidity and mortality of colorectal cancer increaserecently in China. Peritoneal,as a common site of metastasis, is one of the typical causes of treatment failure. Although there are many kinds of peritoneal prophylactic and therapeutic drugs for peritoneal metastasis of colorectal cancer, the dose and time of action have not yet formed a standardized treatment model. In order to standardize intraoperative prophylactic and therapeutic intraperitoneal intervention methods, the experts from Professional Committee of peritoneal metastasis and Colorectal Cancer Committee of Chinese Medical Doctor Association developed "Chinese expert consensus for prophylactic and therapeutic intraperitoneal medication for peritoneal metastases from colorectal cancer". It aims at improving the overall diagnosis and treatment of colorectal cancer, extend the survival time of patients and improve the quality of life.
出处
《中华结直肠疾病电子杂志》
2019年第4期329-335,共7页
Chinese Journal of Colorectal Diseases(Electronic Edition)
关键词
结直肠肿瘤
腹膜转移
腹腔治疗
腹腔化疗
腹腔热灌注化疗
专家共识
Colorectal neoplasms
Peritoneal metastasis
Intraperitoneal treatment
Intraperitoneal chemoperfusion
Hyperthermic intraperitoneal chemotherapy
Expert consensus
